CpG oligonucleotides activate the immune response in burned mice.
暂无分享,去创建一个
N. Takeyama | T. Yabuki | T. Nakatani | H. Noguchi | M. Tsuda | Takaya Tanaka | F. Saitoh
[1] S. Tschoeke,et al. Immunoparalysis after multiple trauma. , 2007, Injury.
[2] A. Ayala,et al. Decreased monocyte human leukocyte antigen-DR expression after severe burn injury: Correlation with severity and secondary septic shock , 2007, Critical care medicine.
[3] D. Chinkes,et al. SERUM CYTOKINE DIFFERENCES IN SEVERELY BURNED CHILDREN WITH AND WITHOUT SEPSIS , 2007, Shock.
[4] N. Klein,et al. Interleukin-10 and its role in clinical immunoparalysis following pediatric cardiac surgery* , 2006, Critical care medicine.
[5] N. Voirin,et al. Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock , 2006, Intensive Care Medicine.
[6] D. Annane,et al. Invited review: Compartmentalization of the inflammatory response in sepsis and SIRS , 2006 .
[7] L. Koenderman,et al. World Journal of Emergency Surgery Open Access Trauma: the Role of the Innate Immune System , 2022 .
[8] D. Church,et al. Burn Wound Infections , 2006, Clinical Microbiology Reviews.
[9] E. Moore,et al. Introducing World Journal of Emergency Surgery , 2006, World journal of emergency surgery : WJES.
[10] H. Repo,et al. Monocyte Anergy Is Present in Patients With Severe Acute Pancreatitis and Is Significantly Alleviated by Granulocyte-Macrophage Colony-stimulating Factor and Interferon-γ In Vitro , 2005, Pancreas.
[11] J. Pugin,et al. Immune monitoring of patients with septic shock by measurement of intraleukocyte cytokines , 2004, Intensive Care Medicine.
[12] N. Shinomiya,et al. Paradoxical Effect of IL-18 Therapy on the Severe and Mild Escherichia coli Infections in Burn-Injured Mice , 2004, Annals of surgery.
[13] S. Pichyangkul,et al. Immunostimulatory CpG Oligodeoxynucleotide Confers Protection in a Murine Model of Infection with Burkholderia pseudomallei , 2004, Infection and Immunity.
[14] D. Klinman. Immunotherapeutic uses of CpG oligodeoxynucleotides , 2004, Nature Reviews Immunology.
[15] L. Babiuk,et al. Protection of Chickens against Escherichia coli Infections by DNA Containing CpG Motifs , 2003, Infection and Immunity.
[16] I. Chaudry,et al. The cellular basis of post-burn immunosuppression: macrophages and mediators. , 2002, International journal of molecular medicine.
[17] S. Pichyangkul,et al. CpG ODN activates NO and iNOS production in mouse macrophage cell line (RAW 264·7) , 2002, Clinical and experimental immunology.
[18] T. Crabtree,et al. Preexposure of Murine Macrophages to CpG Oligonucleotide Results in a Biphasic Tumor Necrosis Factor Alpha Response to Subsequent Lipopolysaccharide Challenge , 2001, Infection and Immunity.
[19] S. Akira,et al. A Toll-like receptor recognizes bacterial DNA , 2000, Nature.
[20] B. Holzmann,et al. Increased Resistance Against Acute Polymicrobial Sepsis in Mice Challenged with Immunostimulatory CpG Oligodeoxynucleotides Is Related to an Enhanced Innate Effector Cell Response1 , 2000, The Journal of Immunology.
[21] E. Rackow,et al. Decreased response to recall antigens is associated with depressed costimulatory receptor expression in septic critically ill patients. , 2000, The Journal of laboratory and clinical medicine.
[22] R. Purcell,et al. Delineation of a CpG Phosphorothioate Oligodeoxynucleotide for Activating Primate Immune Responses In Vitro and In Vivo1 , 2000, The Journal of Immunology.
[23] J. Lederer,et al. Injury induces deficient interleukin-12 production, but interleukin-12 therapy after injury restores resistance to infection. , 2000, Annals of surgery.
[24] N. Pallua,et al. Association between Reduced Human Leukocyte Antigen (HLA)-DR Expression on Blood Monocytes and Increased Plasma Level of Interleukin-10 in Patients with Severe Burns , 1999, Clinical chemistry and laboratory medicine.
[25] S. Stibitz,et al. Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria. , 1999, Journal of immunology.
[26] T. Jakob,et al. Regulation of E-cadherin-mediated adhesion in Langerhans cell-like dendritic cells by inflammatory mediators that mobilize Langerhans cells in vivo. , 1998, Journal of immunology.
[27] D. Hume,et al. Macrophages ingest and are activated by bacterial DNA. , 1996, Journal of immunology.
[28] J. Lederer,et al. Interleukin-12 treatment restores normal resistance to bacterial challenge after burn injury. , 1996, Surgery.
[29] Santa Jeremy Ono,et al. Modulation of MHC class II expression in human cells by dexamethasone. , 1995, Cellular immunology.
[30] I. Chaudry,et al. TRAUMA-HEMORRHAGE CAUSES PROLONGED DEPRESSION IN CELLULAR IMMUNITY , 1995, Shock.
[31] G. Bishop,et al. CpG motifs in bacterial DNA trigger direct B-cell activation , 1995, Nature.
[32] J. Oppenheim,et al. IL-1 and tumor necrosis factor-alpha each up-regulate both the expression of IFN-gamma receptors and enhance IFN-gamma-induced HLA-DR expression on human monocytes and a human monocytic cell line (THP-1). , 1993, Journal of immunology.
[33] J. Ting,et al. A beta-adrenergic agonist modulates DR alpha gene transcription via enhanced cAMP levels in a glioblastoma multiforme line. , 1989, Journal of immunology.
[34] H. Kirchner,et al. Pharmacokinetics of Recombinant Murine Interferon-γ in Mice , 1988 .
[35] A. Meyer,et al. Lack of correlation between decreased chemotaxis and susceptibility to infection in burned rats. , 1986, The Journal of trauma.
[36] S. Lendemans,et al. Differential immunostimulating effect of Granulocyte-macrophage colony-stimulating factor (GM-CSF), Granulocyte colony-stimulating factor (G-CSF) and Interferon γ (IFNγ) after severe trauma , 2007, Inflammation Research.
[37] J. Pugin. Immunostimulation is a rational therapeutic strategy in sepsis. , 2007, Novartis Foundation symposium.
[38] D. Annane,et al. Compartmentalization of the inflammatory response in sepsis and SIRS. , 2006, Journal of endotoxin research.
[39] A. Krieg,et al. CpG motifs in bacterial DNA and their immune effects. , 2002, Annual review of immunology.